Author:
Sato Kiyotaka,Kameyama Motonobu,Katakura Ryuichi,Kayama Takamasa,Yoshimoto Takashi,Ishiwata Kiichi
Reference18 articles.
1. Derlon JM, Bourdet C, Bustany P, Chatel M, Theron J, Darcel F, Syrota A (1989) [11C]L-methionine uptake in gliomas. Neurosurg 25: 720–728
2. Kameyama M, Shirane R, Itoh J, Sato K, Katakura R, Yoshimoto T, Hatazawa J, Itoh M, Ido T (1990) The accumulation of 11C-methionine and histological grade in cerebral glioma patients studied with PET. Acta Neurochir (Wien) 104: 8–12
3. Patronas NJ, Brooks RA, DeLaPaz RL, Smith BH, Kornblith PL and DiChiro G (1983) Glycolytic rate (PET) and contrast enhancement ( CT) in human cerebral gliomas. AJNR 4: 533–535
4. Abe Y, Fukuda H, Ishiwata K, Yoshioka S, Yamada K, Endo S, Kubota K, Sato T, Matsuzawa T, Takahashi T, Ido T (1983) Studies on 18F-labeled pyrimidines. Tumor uptakes of 18F-5-fluorouracil, 18F-5-fluorouridine, 18F-5-fluorodeoxy-uridine in animals. Eur J Nucl Med 8: 258–261
5. Ishiwata K, Ido T, Kawashima K, Murakami M, Takahashi T(1984) Studies on 18F-labeled pyrimidines: II. Metabolic investigation of 18F-5-fluorouracil, 18F-5- fluoro-2′-deoxy- uridine and 18F-5-fluorouridine in rats. Eur J Nucl Med 9: 185–189